Cited 19 times in
Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 염준섭 | - |
dc.contributor.author | 정수진 | - |
dc.date.accessioned | 2022-11-24T00:49:37Z | - |
dc.date.available | 2022-11-24T00:49:37Z | - |
dc.date.issued | 2021-03 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/191010 | - |
dc.description.abstract | Despite the global effort to mitigate the spread, coronavirus disease 2019 (COVID-19) has become a pandemic that took more than 2 million lives. There are numerous ongoing clinical studies aiming to find treatment options and many are being published daily. Some effective treatment options, albeit of variable efficacy, have been discovered. Therefore, it is necessary to develop an evidence-based methodology, to continuously check for new evidence, and to update recommendations accordingly. Here we provide guidelines on pharmaceutical treatment for COVID-19 based on the latest evidence. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | Korean, English | - |
dc.publisher | 대한감염학회 | - |
dc.relation.isPartOf | INFECTION AND CHEMOTHERAPY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19 | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Sun Bean Kim | - |
dc.contributor.googleauthor | Seungeun Ryoo | - |
dc.contributor.googleauthor | Kyungmin Huh | - |
dc.contributor.googleauthor | Eun Jeong Joo | - |
dc.contributor.googleauthor | Youn Jeong Kim | - |
dc.contributor.googleauthor | Won Suk Choi | - |
dc.contributor.googleauthor | Yae Jean Kim | - |
dc.contributor.googleauthor | Young Kyung Yoon | - |
dc.contributor.googleauthor | Jung Yeon Heo | - |
dc.contributor.googleauthor | Yu Bin Seo | - |
dc.contributor.googleauthor | Su Jin Jeong | - |
dc.contributor.googleauthor | Dong Ah Park | - |
dc.contributor.googleauthor | Su Yeon Yu | - |
dc.contributor.googleauthor | Hyeon Jeong Lee | - |
dc.contributor.googleauthor | Jimin Kim | - |
dc.contributor.googleauthor | Yan Jin | - |
dc.contributor.googleauthor | Jungeun Park | - |
dc.contributor.googleauthor | Kyong Ran Peck | - |
dc.contributor.googleauthor | Miyoung Choi | - |
dc.contributor.googleauthor | Joon Sup Yeom | - |
dc.identifier.doi | 10.3947/ic.2021.0303 | - |
dc.contributor.localId | A02353 | - |
dc.contributor.localId | A03638 | - |
dc.relation.journalcode | J01053 | - |
dc.identifier.eissn | 2092-6448 | - |
dc.identifier.pmid | 34409790 | - |
dc.subject.keyword | COVID-19 | - |
dc.subject.keyword | Clinical practice guidelines | - |
dc.subject.keyword | Korea | - |
dc.contributor.alternativeName | Yeom, Joon Sup | - |
dc.contributor.affiliatedAuthor | 염준섭 | - |
dc.contributor.affiliatedAuthor | 정수진 | - |
dc.citation.volume | 53 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 166 | - |
dc.citation.endPage | 219 | - |
dc.identifier.bibliographicCitation | INFECTION AND CHEMOTHERAPY, Vol.53(1) : 166-219, 2021-03 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.